# GCC Hydrophobic Interaction Chromatography Market > GCC Hydrophobic Interaction Chromatography Market Research Report: By Product and Service (Resins, Columns, Services, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.66% - **2024:** $ 20.9 Million - **2025:** $ 22.71 Million - **2035:** $ 52.09 Million - **Key Players:** GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) **Report ID:** MRFR/HC/54732-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/gcc-hydrophobic-interaction-chromatography-market-56498 --- ## Market Summary ## **GCC Hydrophobic Interaction Chromatography Market Overview****:** As per MRFR analysis, the GCC Hydrophobic Interaction Chromatography Market Size was estimated at 4.83 (USD Million) in 2023.The GCC Hydrophobic Interaction Chromatography Market Industry is expected to grow from 5.21(USD Million) in 2024 to 11.73 (USD Million) by 2035. The GCC Hydrophobic Interaction Chromatography Market CAGR (growth rate) is expected to be around 7.665% during the forecast period (2025 - 2035). ### **Key GCC Hydrophobic Interaction Chromatography Market Trends Highlighted** The GCC Hydrophobic Interaction Chromatography market is striding with the development trends of the biopharmaceutical market in the area. The GCC governments have put a lot of focus on biomedicine, and policies supporting innovation and development have appeared. This is certainly augmenting the need for advanced chromatographic methods, especially hydrophobic interaction chromatography, which plays a crucial role in protein purification processes. Recently, both biopharmaceutical facilities and the supporting public sectors have increased their investment activities. Nations such as Saudi Arabia along with the United Arab Emirates are actively sponsoring projects to enable them to become the regional life sciences center which provides great opportunities in laboratory technologies and chromatography solutions. With the steady demand for healthcare services and the greater emphasis on the biopharma R&D, there are ample opportunities for local and global vendors to partner and create more efficient and high quality products. Moreover, the shift towards the production of biopharmaceutical medicines locally is causing a need for sophisticated analytical instruments such as hydrophobic interaction chromatography. This is due to a need to guarantee adherence to more international standards and regulations, as is the case in the GCC countries which is increasingly adopting global best practices. Therefore, there is a greater tendency among companies to make investments in teaching and education in order to develop the human resources in this area. In summary, the development trends in the biopharmaceuticals sector in the GCC region will determine the future of the hydrophobic interaction chromatography market in the region. ## **GCC Hydrophobic Interaction Chromatography Market Drivers** ### **Growing Biopharmaceutical Industry in GCC** The biopharmaceutical industry in the Gulf Cooperation Council (GCC) region is witnessing significant growth, greatly impacting the GCC Hydrophobic Interaction Chromatography Market Industry. The GCC has seen an increase in biopharmaceutical production facilities, with countries like Saudi Arabia and the United Arab Emirates investing heavily in modern production plants. According to the Saudi Food and Drug Authority, there has been a 30% increase in biopharmaceutical approvals in the last three years.This surge is largely due to government initiatives focused on healthcare innovation. For instance, the Kingdom of Saudi Arabia's Vision 2030 agenda includes plans to enhance the local pharmaceutical manufacturing sector, thereby amplifying the demand for advanced chromatography techniques, including Hydrophobic Interaction Chromatography, to purify and separate biomolecules efficiently. ### **Rising Demand for Therapeutics and Vaccines** The ongoing demand for novel therapeutics and vaccines in the GCC is a major driver for the GCC [Hydrophobic Interaction Chromatography Market](../../../reports/hydrophobic-interaction-chromatography-market-6366) Industry. Recent health crises, including the COVID-19 pandemic, have underscored the need for rapid and effective vaccine development. The World Health Organization reported over a 45% increase in research funding for vaccine development across GCC countries, notably during the pandemic. In response, GCC governments are prioritizing biotechnology research and development, further fueling the adoption of chromatography techniques for vaccine purification, as seen in various local health initiatives by organizations like G42 Healthcare in the UAE. ### **Technological Advancements in Chromatography Techniques** Technological advancements in chromatography techniques are propelling growth in the GCC Hydrophobic Interaction Chromatography Market Industry. With innovative technologies enhancing the efficiency and accuracy of hydrophobic interaction chromatography, laboratories in the GCC are increasingly adopting these methodologies. A definitive trend has been noted where laboratories are investing approximately 25% more in chromatography equipment over the last two years to improve separation techniques.Organizations such as the Kuwait Institute for Scientific Research are pioneering the implementation of high-performance liquid chromatography systems, positioning themselves as leaders in the region. ## **GCC Hydrophobic Interaction Chromatography Market Segment Insights****:** ### **Hydrophobic Interaction Chromatography Market Product and Service Insights** The Product and Service segment of the GCC Hydrophobic Interaction Chromatography Market exhibits a diverse and dynamic landscape that emphasizes the essential components driving the region's bioprocessing and purification industries. In particular, Resins are instrumental in facilitating the efficient separation and purification of proteins, playing a vital role due to their high binding capacities and selectivity for target molecules.  The columns used in the chromatography process are equally significant, as they dictate the overall performance and efficiency of the separation processes.They are designed to handle various scales of production, from small laboratory settings to large industrial applications, thus adapting to the growing needs of the GCC's pharmaceutical and biotechnology sectors. Services inclined towards installation, maintenance, and support of chromatography systems are crucial as they ensure optimal performance, reliability, and durability of the chromatography setup.  Additionally, the 'Others' category includes a range of ancillary products and services that contribute to the overall effectiveness of hydrophobic interaction chromatography, enhancing operational efficiency and research capabilities.The importance of these components cannot be overstated, as they not only support the routine workings of laboratories but also enable advancements in research and development within the healthcare and life science industries in the GCC region. As the demand for biopharmaceuticals continues to rise, the GCC Hydrophobic Interaction Chromatography Market is poised for steady growth, highlighting the indispensable nature of the Product and Service segment in meeting contemporary processing challenges and fostering innovation within this critical field. ## **GCC Hydrophobic Interaction Chromatography Market Key Players and Competitive Insights****:** The GCC Hydrophobic Interaction Chromatography Market has become increasingly competitive as the demand for advanced separation techniques grows within the biopharmaceutical and biotechnology sectors. Hydrophobic interaction chromatography (HIC) has emerged as a crucial method for purifying proteins and biomolecules due to its ability to exploit hydrophobic interactions between the target molecules and the stationary phase. As technological advancements in chromatography evolve, companies are focusing on enhancing their product offerings and market strategies to cater to varying customer needs, including scalability, speed, and efficiency.  The competitive landscape is characterized by the presence of both established firms and emerging players that are striving to gain market share by leveraging innovative technologies, product differentiation, and strategic alliances. In addition to conventional chromatography solutions, companies are increasingly aligning themselves with trends such as automation, customization, and integrated bioprocessing to enhance their value propositions and maintain a competitive edge.Abcam has established its presence in the GCC Hydrophobic Interaction Chromatography Market through a strong portfolio of high-quality products that cater specifically to life sciences and research applications.  The company's commitment to providing exceptional customer service and technical support has garnered a loyal clientele within the region. Abcam's strengths lie in its extensive catalog of reagents and purification kits designed for hydrophobic interaction chromatography, which are backed by robust research and development initiatives. The company's reputation for reliability and innovation enhances its competitive positioning, allowing it to address the specific needs of researchers and institutions across the Gulf Cooperation Council area. By maintaining a focus on quality and customer satisfaction, Abcam continues to solidify its role as a key player within this specialized market.Q2 Solutions stands out in the GCC Hydrophobic Interaction Chromatography Market primarily due to its comprehensive suite of services aimed at supporting drug development and biopharmaceutical research.  The company offers a variety of chromatography services that include not only hydrophobic interaction chromatography but also associated analytical and bioprocessing capabilities that ensure a holistic solution for its clients. With a notable presence in major GCC countries, Q2 Solutions has formed strategic partnerships and alliances that have strengthened its market reach. The company’s strengths lie in its state-of-the-art facilities and the team of experts who deliver high-quality, efficient solutions tailored to the demands of the GCC market. Q2 Solutions has also made key investments in technology and also engages in mergers and acquisitions to expand its service offerings and enhance competitive advantages. By focusing on improving methodologies and increasing its operational capacity, Q2 Solutions continues to play a significant role in fulfilling the growing demand for advanced chromatographic techniques within the region. ### **Key Companies in the GCC Hydrophobic Interaction Chromatography Market Include:** - Abcam - Q2 Solutions - Fujifilm Diosynth Biotechnologies - PerkinElmer - Sartorius AG - BioRad Laboratories - Thermo Fisher Scientific - Roche - GE Healthcare - Gibco - Lonza Group - Merck KGaA - Agilent Technologies - Waters Corporation - Pall Corporation ## **GCC Hydrophobic Interaction Chromatography Market Industry Developments** Recent developments in the GCC Hydrophobic Interaction Chromatography Market have been marked by a notable increase in investments and advancements from companies such as Thermo Fisher Scientific and Sartorius AG. In October 2023, Abcam announced the launch of new products aimed at enhancing protein purification processes, illustrating a growing trend towards innovation in this sector. Additionally, major corporations are witnessing growth in their market valuations, contributing to an overall optimistic outlook in the region. Merger and acquisition activities have also shaped the landscape, with Fujifilm Diosynth Biotechnologies acquiring a local biomanufacturing company in September 2023 to expand its capabilities within the GCC region.  The regulatory landscape has become more favorable, with several GCC nations streamlining the approval processes for biotechnology and laboratory-related applications, thus facilitating market expansion. Over the past two to three years, companies like Merck KGaA and BioRad Laboratories have made substantial progress in establishing regional headquarters, which further enhances the GCC's role as a hub for life sciences. This strategic positioning aligns with government initiatives to bolster the biopharmaceutical sector across the Gulf Cooperation Council member states. ## **GCC Hydrophobic Interaction Chromatography Market Segmentation Insights** ### **Hydrophobic Interaction Chromatography Market Product and Service****Outlook** - Resins - Columns - Services - Others ## Market Drivers ### Growing Focus on Quality Control Quality control is becoming increasingly critical in the GCC region, particularly in the pharmaceutical and biotechnology sectors. The hydrophobic interaction-chromatography market is poised to benefit from this trend as companies strive to meet stringent quality standards. Regulatory bodies are emphasizing the need for reliable purification methods to ensure the safety and efficacy of biopharmaceutical products. Hydrophobic interaction chromatography is recognized for its ability to provide high purity levels, making it a preferred choice for quality control processes. As the GCC region enhances its regulatory framework, the demand for effective quality control measures is expected to rise, thereby driving the hydrophobic interaction-chromatography market. Companies that invest in advanced chromatography technologies are likely to gain a competitive edge in ensuring compliance with evolving quality standards. ### Expansion of Biotechnology Sector The biotechnology sector in the GCC is witnessing substantial expansion, which is positively impacting the hydrophobic interaction-chromatography market. Governments in the region are actively promoting biotechnology initiatives to diversify their economies and enhance healthcare solutions. This expansion is leading to an increased demand for advanced purification techniques, including hydrophobic interaction chromatography, which is essential for the development of biopharmaceuticals and diagnostics. The biotechnology market in the GCC is expected to grow at a CAGR of around 10% over the next few years, indicating a robust demand for effective separation technologies. As more biotechnology companies emerge, the need for reliable and efficient purification methods will likely drive the growth of the hydrophobic interaction-chromatography market. ### Increasing Biopharmaceutical Production The hydrophobic interaction-chromatography market is experiencing growth due to the rising production of biopharmaceuticals in the GCC region. As biopharmaceuticals require sophisticated purification processes, hydrophobic interaction chromatography has become essential for isolating proteins and other biomolecules. The GCC biopharmaceutical market is projected to reach approximately $5 billion by 2026, indicating a robust demand for effective purification techniques. This trend is likely to drive investments in advanced chromatography systems, enhancing the capabilities of laboratories and manufacturing facilities. Furthermore, the increasing focus on monoclonal antibodies and therapeutic proteins necessitates the use of hydrophobic interaction-chromatography, which is known for its efficiency in separating biomolecules based on hydrophobicity. Consequently, the growth in biopharmaceutical production is a significant driver for the hydrophobic interaction-chromatography market in the region. ### Rising Research and Development Activities The hydrophobic interaction-chromatography market is benefiting from the surge in research and development activities across various sectors, particularly in biotechnology and pharmaceuticals. GCC countries are investing heavily in R&D to foster innovation and enhance their healthcare systems. This investment is reflected in the increasing number of research institutions and laboratories that require advanced purification techniques. The demand for hydrophobic interaction chromatography is likely to rise as researchers seek efficient methods for protein purification and characterization. Moreover, the GCC region's commitment to diversifying its economy and reducing reliance on oil is driving the establishment of biotechnology hubs, further propelling the need for sophisticated chromatography solutions. As a result, the growth in R&D activities is a crucial driver for the hydrophobic interaction-chromatography market. ### Technological Innovations in Chromatography Technological innovations are playing a pivotal role in shaping the hydrophobic interaction-chromatography market. The introduction of advanced chromatography systems and materials is enhancing the efficiency and effectiveness of purification processes. Innovations such as high-throughput screening and automated systems are streamlining workflows, making hydrophobic interaction chromatography more accessible to laboratories in the GCC region. These advancements are likely to reduce operational costs and improve the overall productivity of biopharmaceutical manufacturing. Furthermore, the integration of artificial intelligence and data analytics in chromatography systems is expected to optimize purification protocols, leading to better outcomes. As technology continues to evolve, it is anticipated that the hydrophobic interaction-chromatography market will experience significant growth driven by these innovations. ## Future Outlook The [Hydrophobic Interaction Chromatography Market](https://www.marketresearchfuture.com/reports/hydrophobic-interaction-chromatography-market-6366) is projected to grow at an 8.66% CAGR from 2025 to 2035, driven by increasing biopharmaceutical production and demand for purification technologies. **New opportunities:** - Development of advanced resin technologies for enhanced separation efficiency. - Expansion of service offerings for customized chromatography solutions. - Investment in automation technologies for streamlined laboratory processes. By 2035, the market is expected to achieve substantial growth, driven by innovation and strategic investments. ## Segment Insights ### By Product and Service: Resins (Largest) vs. Buffers (Fastest-Growing) In the GCC hydrophobic interaction-chromatography market, the product and service segment showcases a diverse distribution among its constituents. Resins hold the largest share of this segment, benefitting from their essential role in purification processes. Following closely are buffers and columns, which play critical roles in maintaining pH levels and facilitating efficient separation. Other products and services collectively contribute, yet have a smaller market footprint compared to these leading categories. Growth trends indicate a burgeoning demand for buffers, which are observed as the fastest-growing segment within the product and service category. This surge is driven by advancements in biopharmaceutical processes that require high-purity and efficient chromatographic solutions. Additionally, the continuous innovation in resin technology, aimed at enhancing resolution and speed, complements the growth trajectory, ensuring that these products meet the evolving needs of the market. Resins (Dominant) vs. Buffers (Emerging) Resins are the cornerstone of the GCC hydrophobic interaction-chromatography market, establishing dominance due to their critical function in various purification workflows. Their superior selectivity and capacity make them indispensable across a wide range of applications in biotech and pharmaceutical sectors. Meanwhile, buffers are emerging as a significant player, characterized by their essential role in facilitating optimal chromatographic conditions. As the demand for high-performance purification solutions escalates, the innovation in buffer formulations is driven by the need for enhanced stability and reproducibility. This has positioned buffers as a key focus area for growth, challenging traditional resin applications and redefining market dynamics. ### By Sample Type: Monoclonal Antibodies (Largest) vs. Vaccines (Fastest-Growing) The GCC hydrophobic interaction-chromatography market showcases a diverse landscape in the sample type segment. Monoclonal antibodies hold the largest share, reflecting their critical role in biopharmaceuticals and therapeutics. In contrast, vaccines are rapidly gaining market traction, driven by increased investment in vaccine research and development. This dynamic is indicative of the evolving healthcare market and the necessity for efficient separation technologies. Growth trends for the sample type segment are propelled by technological advancements in chromatography techniques and rising demand for biopharmaceuticals. The increasing prevalence of chronic diseases and the urgent need for effective vaccine development, especially highlighted during the pandemic, further underscore the role of hydrophobic interaction-chromatography. As these segments evolve, they will continue to influence market dynamics significantly. Monoclonal Antibodies: Dominant vs. Vaccines: Emerging Monoclonal antibodies are recognized as the dominant player in the GCC hydrophobic interaction-chromatography market due to their wide application in therapeutic and diagnostic products. Their well-established use in targeted therapies makes them a crucial segment. On the other hand, vaccines are emerging as a compelling segment, facilitated by a surge in demand for innovative vaccine solutions. This rise is influenced by global health initiatives and increasing awareness regarding preventable diseases. As both segments develop, they are expected to leverage advancements in chromatography technologies to enhance purity and yield, further solidifying their market positions. ### By End-User: Pharmaceutical & Biopharmaceutical Companies (Largest) vs. Contract Research Organizations & Contract Manufacturing Organizations (Fastest-Growing) In the GCC hydrophobic interaction-chromatography market, the market share distribution indicates that Pharmaceutical & Biopharmaceutical Companies constitute the largest segment due to their ongoing investment in drug development and production. This segment benefits from a robust demand for purification processes in the development of therapeutic proteins and monoclonal antibodies, solidifying its dominant position in the market. On the other hand, Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs) are recognized as the fastest-growing segments. Their accelerated growth can be attributed to the rising trend of outsourcing by pharmaceutical companies seeking cost-effective solutions and rapid scalability. Innovative technologies and increasing collaborations are driving these organizations to expand their service offerings and improve operational efficiencies. Pharmaceutical & Biopharmaceutical Companies (Dominant) vs. Contract Research Organizations & Contract Manufacturing Organizations (Emerging) The Pharmaceutical & Biopharmaceutical Companies segment is characterized by extensive research and development (R&D) activities aimed at advancing therapeutic innovations. Dominating the market, this segment relies heavily on hydrophobic interaction-chromatography for efficient protein purification and ensuring the quality of biopharmaceuticals. In contrast, the Contract Research Organizations & Contract Manufacturing Organizations segment is emerging robustly, offering a range of tailored services that help streamline processes for pharmaceutical companies. They are increasingly pivotal in providing outsourced production and clinical development services, facilitating timely product launches and cost savings. Together, these segments highlight the dynamic nature of the market, reflecting the shift towards specialized and efficient practices in the industry. ## Competitive Benchmarking The hydrophobic interaction-chromatography market exhibits a dynamic competitive landscape, characterized by a blend of innovation and strategic partnerships among key players. Major companies such as GE Healthcare (US), Thermo Fisher Scientific (US), and Merck KGaA (DE) are at the forefront, leveraging their extensive portfolios to drive growth. GE Healthcare (US) focuses on enhancing its product offerings through technological advancements, while Thermo Fisher Scientific (US) emphasizes regional expansion and customer-centric solutions. Merck KGaA (DE) appears to be investing heavily in R&D to foster innovation, which collectively shapes a competitive environment that is increasingly reliant on technological differentiation and strategic collaborations.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure is moderately fragmented, with a mix of established players and emerging companies vying for market share. This fragmentation allows for diverse strategies, as key players leverage their strengths to influence market dynamics. The collective influence of these companies fosters a competitive atmosphere where innovation and customer engagement are paramount. In October Thermo Fisher Scientific (US) announced a strategic partnership with a leading biotechnology firm to co-develop advanced chromatography solutions. This collaboration is likely to enhance their product offerings and expand their market reach, indicating a shift towards more integrated solutions in the chromatography space. Such partnerships may also facilitate knowledge sharing and innovation, positioning Thermo Fisher as a leader in the market. In September Merck KGaA (DE) launched a new line of hydrophobic interaction-chromatography resins designed for high-throughput applications. This introduction not only reflects Merck's commitment to innovation but also addresses the growing demand for efficient and scalable solutions in biopharmaceutical manufacturing. The strategic importance of this launch lies in its potential to capture a larger market share by meeting the specific needs of biopharmaceutical companies. In August GE Healthcare (US) expanded its manufacturing capabilities in the GCC region, aiming to enhance local production of chromatography products. This move is indicative of a broader trend towards regional manufacturing, which may reduce lead times and improve supply chain reliability. By establishing a stronger local presence, GE Healthcare is likely to strengthen its competitive position and respond more effectively to regional market demands. As of November current trends in the hydrophobic interaction-chromatography market include a pronounced focus on digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, as companies seek to combine resources and expertise to drive innovation. The evolution of competitive differentiation appears to be shifting from price-based competition towards a focus on technological advancements and supply chain reliability. This transition suggests that companies that prioritize innovation and customer-centric solutions will likely emerge as leaders in the market. ## Recent News & Developments Recent developments in the GCC Hydrophobic Interaction Chromatography Market have been marked by a notable increase in investments and advancements from companies such as Thermo Fisher Scientific and Sartorius AG. In October 2023, Abcam announced the launch of new products aimed at enhancing protein purification processes, illustrating a growing trend towards innovation in this sector. Additionally, major corporations are witnessing growth in their market valuations, contributing to an overall optimistic outlook in the region. Merger and acquisition activities have also shaped the landscape, with Fujifilm Diosynth Biotechnologies acquiring a local biomanufacturing company in September 2023 to expand its capabilities within the GCC region.  The regulatory landscape has become more favorable, with several GCC nations streamlining the approval processes for biotechnology and laboratory-related applications, thus facilitating market expansion. Over the past two to three years, companies like Merck KGaA and BioRad Laboratories have made substantial progress in establishing regional headquarters, which further enhances the GCC's role as a hub for life sciences. This strategic positioning aligns with government initiatives to bolster the biopharmaceutical sector across the Gulf Cooperation Council member states. ## Report Scope | MARKET SIZE 2024 | 20.9(USD Million) | | --- | --- | | MARKET SIZE 2025 | 22.71(USD Million) | | MARKET SIZE 2035 | 52.09(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.66% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Thermo Fisher Scientific (US), Merck KGaA (DE), Agilent Technologies (US), Bio-Rad Laboratories (US), Waters Corporation (US), Pall Corporation (US), Repligen Corporation (US) | | Segments Covered | Product and Service, Sample Type, End-User | | Key Market Opportunities | Growing demand for biopharmaceuticals drives innovation in the hydrophobic interaction-chromatography market. | | Key Market Dynamics | Rising demand for biopharmaceuticals drives innovation and competition in the hydrophobic interaction-chromatography market. | | Countries Covered | GCC | ## Frequently Asked Questions **Q: What was the market valuation of the GCC hydrophobic interaction-chromatography market in 2024?** A: The market valuation was $20.9 Million in 2024. **Q: What is the projected market valuation for the GCC hydrophobic interaction-chromatography market by 2035?** A: The projected valuation for 2035 is $52.09 Million. **Q: What is the expected CAGR for the GCC hydrophobic interaction-chromatography market during the forecast period 2025 - 2035?** A: The expected CAGR is 8.66% during the forecast period 2025 - 2035. **Q: Which companies are considered key players in the GCC hydrophobic interaction-chromatography market?** A: Key players include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Bio-Rad Laboratories, Waters Corporation, Pall Corporation, and Repligen Corporation. **Q: What are the main product segments in the GCC hydrophobic interaction-chromatography market?** A: Main product segments include Resins, Columns, Buffers, and Other Products and Services. **Q: What was the valuation of the Resins segment in 2024?** A: The Resins segment was valued at $5.0 Million in 2024. **Q: How much is the Monoclonal Antibodies segment projected to be worth by 2035?** A: The Monoclonal Antibodies segment is projected to reach $20.52 Million by 2035. **Q: What is the valuation of the Pharmaceutical & Biopharmaceutical Companies segment in 2024?** A: The Pharmaceutical & Biopharmaceutical Companies segment was valued at $8.37 Million in 2024. **Q: What is the expected growth trend for the Other Products and Services segment?** A: The Other Products and Services segment is expected to grow from $5.9 Million in 2024 to $15.09 Million by 2035. **Q: Which end-user segment had the lowest valuation in 2024?** A: The Others end-user segment had the lowest valuation at $3.12 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/gcc-hydrophobic-interaction-chromatography-market-56498*